about
Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial.Peripheral Th17/Treg imbalance in elderly patients with ischemic stroke.Regulatory T and T helper 17 cells: Their roles in preeclampsia.Current approaches for the treatment of male infertility with stem cell therapy.Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's diseaseAnti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing miceEvaluation of ovarian cancer risk in granulosa cells treated with steroid-depleted endometriosis serum: Role of NF-κB/RelA and AKTNatural killer cell-based immunotherapy: From transplantation toward targeting cancer stem cellsCRISPR/Cas9 technology as a potent molecular tool for gene therapyMicroRNAs in breast cancer: Roles, functions, and mechanism of actionsThe roles of signaling pathways in liver repair and regenerationRAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progressionNovel therapeutic approaches in utilizing platelet lysate in regenerative medicine: Are we ready for clinical use?Critical roles of long noncoding RNAs in breast cancerProspect of mesenchymal stem cells in therapy of osteoporosis: A reviewCoinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells
P50
Q47384625-AAC19158-F7A9-467F-84C3-E02E4383CA6FQ48201801-B57D610D-19C5-4290-980D-D5998782CAF9Q52583932-2A129D2B-BAA8-4E84-836A-7460A4B579B5Q53691975-AA770692-7D9D-423E-A9A2-37608DC052DCQ57467249-DA2671ED-2FFF-476B-96EF-2D66FDD4237AQ88614038-282C7616-2772-4AB8-B172-F50460B6F1F9Q90265977-5809BAFF-A720-44BA-87A2-A5E69508F7D8Q91136961-85DC5161-3350-4E63-A4FE-1C663999D8A8Q91274262-50CE0A52-5FF2-4AE3-A869-004F8B9CA371Q91277042-F58F78E9-DDBD-4FBF-9152-D33E1B082D0BQ91634190-E1B3D99C-17D7-4C96-8871-0BEF32197667Q91961443-13DC5304-5B7D-465C-8253-A647FA49B756Q92620660-D79BF1B5-7D0C-4898-A187-04BA76823E96Q92724973-27AE2B7D-B3D6-4EF0-9676-524E32ED0597Q93386325-33B044B5-A149-4E97-994C-7A24A37F5459Q95337798-2E52F1F1-0520-426A-8838-56FC93EEA940
P50
description
researcher (ORCID 0000-0001-9823-5454)
@en
name
Mehdi Yousefi
@en
type
label
Mehdi Yousefi
@en
prefLabel
Mehdi Yousefi
@en
P31
P496
0000-0001-9823-5454